
Medibio Ltd
ASX:MEB

Fundamental Analysis


Revenue & Expenses Breakdown
Medibio Ltd
Balance Sheet Decomposition
Medibio Ltd
Current Assets | 304.5k |
Cash & Short-Term Investments | 214.1k |
Other Current Assets | 90.4k |
Non-Current Assets | 7.8m |
PP&E | 107.5k |
Intangibles | 7.6m |
Other Non-Current Assets | 15.2k |
Free Cash Flow Analysis
Medibio Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Medibio Ltd
Revenue
|
963.8k
AUD
|
Cost of Revenue
|
-160
AUD
|
Gross Profit
|
963.6k
AUD
|
Operating Expenses
|
-2.8m
AUD
|
Operating Income
|
-1.8m
AUD
|
Other Expenses
|
-1.3m
AUD
|
Net Income
|
-3.1m
AUD
|
MEB Profitability Score
Profitability Due Diligence
Medibio Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Score
Medibio Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
MEB Solvency Score
Solvency Due Diligence
Medibio Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Score
Medibio Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEB Price Targets Summary
Medibio Ltd
Dividends
Current shareholder yield for MEB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?